Urinary bladder cancer: role of MR imaging.
暂无分享,去创建一个
Sadhna Verma | S. Verma | S. Prasad | V. Mouraviev | K. Gaitonde | K. Sandrasegaran | A. Rajesh | C. Lall | Srinivasa R Prasad | Kumaresan Sandrasegaran | Vladimir Mouraviev | Krishnanath Gaitonde | Arumugam Rajesh | Chandana G Lall | Gunjan Aeron | Robert B Bracken | R. Bracken | G. Aeron
[1] S. Groshen,et al. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. , 1998, Cancer research.
[2] J. Montie,et al. The role of imaging in the surveillance of urologic malignancies. , 2006, The Urologic clinics of North America.
[3] R. Dunn,et al. Understanding bladder cancer death , 2009, Cancer.
[4] N. Cowan,et al. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour , 2007, BJU international.
[5] Xue-Ru Wu. Urothelial tumorigenesis: a tale of divergent pathways , 2005, Nature Reviews Cancer.
[6] V B Ho,et al. Chemical shift: the artifact and clinical tool revisited. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.
[7] R. Günther,et al. Staging of urinary bladder neoplasms with MR imaging: is Gd-DTPA helpful? , 1991, Journal of computer assisted tomography.
[8] P. Rigatti,et al. Dynamic gadolinium-enhanced magnetic resonance imaging in staging of superficial bladder cancer. , 1996, The Journal of urology.
[9] Tarek El-Diasty,et al. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. , 2009, Radiology.
[10] W. Murphy,et al. Tumors of the kidney, bladder, and related urinary structures , 2004 .
[11] D. Skinner,et al. Diagnosis and Management of Genitourinary Cancer , 1987 .
[12] Dow-Mu Koh,et al. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. , 2007, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[13] Cary Siegel,et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] K. Kihara,et al. Initial experience of diffusion-weighted magnetic resonance imaging to assess therapeutic response to induction chemoradiotherapy against muscle-invasive bladder cancer. , 2010, Urology.
[15] K. Czene,et al. Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish family‐cancer database , 2002, International journal of cancer.
[16] L. Kiemeney,et al. Familial aggregation of urothelial cell carcinoma , 2002, International journal of cancer.
[17] A. Tanimoto,et al. Bladder tumor staging: comparison of conventional and gadolinium-enhanced dynamic MR imaging and CT. , 1992, Radiology.
[18] R. Guenther,et al. Urinary bladder neoplasms: evaluation with contrast-enhanced MR imaging. , 1989, Radiology.
[19] S. Verma,et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. , 2011, AJR. American journal of roentgenology.
[20] N. Cowan,et al. Evaluation of multidetector computed tomography urography and ultrasonography for diagnosing bladder cancer. , 2008, Clinical radiology.
[21] N. Cowan,et al. Computed tomography urography for diagnosing bladder cancer , 2006, BJU international.
[22] Takeo Ishigaki,et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate , 2005, Journal of magnetic resonance imaging : JMRI.
[23] W. Sexton,et al. Bladder cancer: a review of non-muscle invasive disease. , 2010, Cancer control : journal of the Moffitt Cancer Center.
[24] Michael Cookson,et al. Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. , 2001, The Journal of urology.
[25] Liang Cheng,et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. , 2005, Urology.
[26] Alberto Redaelli,et al. Bladder cancer: epidemiology, diagnosis, and management. , 2002, Cancer practice.
[27] N. Malats,et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death , 2007, World Journal of Urology.
[28] A. Woodman,et al. A study comparing various noninvasive methods of detecting bladder cancer in urine , 2002, BJU international.
[29] Tarek El-Diasty,et al. Bladder tumour staging: comparison of diffusion- and T2-weighted MR imaging , 2009, European Radiology.
[30] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[31] H. Herr,et al. The value of a second transurethral resection in evaluating patients with bladder tumors. , 2000, The Journal of urology.
[32] D. Bluemke,et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. , 2005, AJR. American journal of roentgenology.
[33] A. Sabichi,et al. Clinical model of lifetime cost of treating bladder cancer and associated complications. , 2006, Urology.
[34] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[35] Kazuro Sugimura,et al. Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.
[36] I. Sesterhenn,et al. From the Archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.
[37] Richard H Cohan,et al. MDCT urography of upper tract urothelial neoplasms. , 2005, AJR. American journal of roentgenology.
[38] S. Kropf,et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. , 2004, The Journal of urology.
[39] M. Caterino,et al. Primary cancer of the urinary bladder: CT evaluation of the T parameter with different techniques , 2001, Abdominal Imaging.
[40] M. Kanematsu,et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value? , 2009, AJR. American journal of roentgenology.
[41] G. Bartsch,et al. Early results of bladder‐cancer screening in a high‐risk population of heavy smokers , 2008, BJU international.
[42] Jingbo Zhang,et al. Imaging of bladder cancer. , 2007, Radiologic clinics of North America.
[43] D. Collins,et al. TECHNICAL ARTICLE: Fusion of high b‐value diffusion‐weighted and T2‐weighted MR images improves identification of lymph nodes in the pelvis , 2010, Journal of medical imaging and radiation oncology.
[44] Dimitrios Giannakis,et al. 16-MDCT cystoscopy in the evaluation of neoplasms of the urinary bladder. , 2008, AJR. American journal of roentgenology.
[45] J. Barentsz,et al. Staging urinary bladder cancer: value of T1-weighted three-dimensional magnetization prepared-rapid gradient-echo and two-dimensional spin-echo sequences. , 1995, AJR. American journal of roentgenology.
[46] K. Kuriyama,et al. Bladder tumors: staging with gadolinium-enhanced oblique MR imaging. , 1993, Radiology.
[47] Fuminari Tatsugami,et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results , 2006, European Radiology.
[48] P. Carroll,et al. Bladder tumor staging: comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging. , 1994, Radiology.
[49] V. Ficarra,et al. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma , 2005, BJU international.
[50] E Dorant,et al. The impact of characteristics of cigarette smoking on urinary tract cancer risk , 2000, Cancer.
[51] Yuta Shibamoto,et al. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. , 2009, Radiology.
[52] Yair Lotan,et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy , 2008, Cancer.
[53] J. Kawamura,et al. A new staging criterion for bladder carcinoma using gadolinium‐enhanced magnetic resonance imaging with an endorectal surface coil: a comparison with ultrasonography , 2000, BJU international.
[54] L. Lawler. MR imaging of the bladder. , 2003, Radiologic clinics of North America.
[55] J. Barentsz,et al. The role of MR imaging in carcinoma of the urinary bladder. , 1993, AJR. American journal of roentgenology.
[56] S. Silverman,et al. Bladder cancer detection with CT urography in an Academic Medical Center. , 2008, Radiology.
[57] M. Resnick,et al. Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. , 2000, The Journal of urology.
[58] Richard C. Semelka,et al. Abdominal-Pelvic MRI , 2002 .
[59] Angela Mariotto,et al. Cost of care for elderly cancer patients in the United States. , 2008, Journal of the National Cancer Institute.
[60] L. Mortelmans,et al. FDG-PET for preoperative staging of bladder cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[61] C. Kim,et al. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. , 2010, AJR. American journal of roentgenology.
[62] H. Hricak,et al. Bladder cancer: can imaging change patient management? , 2008, Current opinion in urology.